CD99 and cytokeratin-20 in small-cell and basaloid tumors of the skin

Applied Immunohistochemistry

Volumn 8, Issue 1, 2000, Pages 37-41

  Nicholson, Siobhan A ^a,d   McDermott, Michael B ^b   Swanson, Paul E ^a   Wick, Mark R ^c  

^a WASHINGTON UNIVERSITY   (United States)

^b OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^d ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

CD99 Cytokeratin subclasses; Cutaneous adnexal tumors; Neuroendocrine carcinoma; Primitive neuroectodermal tumor

Indexed keywords

CD99 ANTIGEN; CYTOKERATIN 20;

ARTICLE; BASAL CELL CARCINOMA; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SKIN TUMOR; TUMOR CLASSIFICATION; TUMOR LOCALIZATION;

ADENOMA, SWEAT GLAND; ANTIGENS, CD; CARCINOMA, ADENOID CYSTIC; CARCINOMA, MERKEL CELL; CELL ADHESION MOLECULES; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; KERATIN-20; NEUROECTODERMAL TUMORS, PRIMITIVE; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034020770     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: 10.1097/00022744-200003000-00006     Document Type: Article

References (38)

1. Dehner LP. Primitive neuroectodermal tumor and Ewing's sarcoma. Am J Surg Pathol 1993;17:1-13.
2. Llombart-Bosch A, Terrier-Lacombe JM, Peydro-Olaya A, Contesso G. Peripheral neuroectodermal sarcoma of soft tissue (peripheral neuroepithelioma): a pathologic study of ten cases with differential diagnosis regarding other small, round cell sarcomas. Hum Pathol 1989;20:273-80.
3. Soon Lee C, Southey MC, Slater H, Auldist AW, Chow CW, Venter DJ. Primary cutaneous Ewing's sarcoma/peripheral primitive neuroectodermal tumors in childhood. Diagn Mol Pathol 1995;4:174-81.
4. Perlman EJ, Lumadue JA, Hawkins AL, Cohen K, Colombani P, Griffin CA. Primary cutaneous neuroendocrine tumors. Diagnostic use of cytogenetic and MIC2 analysis. Cancer Genet Cytogenet 1995;82:30-4.
5. Sexton CW, White WL, Primary cutaneous Ewing's family sarcoma. Report of a case with immunostaining for glycoprotein p30/ 32 mic 2. Am J Dermatopathol 1996;18:601-5.
6. Hasewaga SL, Davison JM, Rutten A, Fletcher JA, Fletcher CD. Primary cutaneous Ewing's sarcoma. Immunophenotypic and molecular cytogenetic evaluation of five cases. Am J Surg Pathol 1998;22:310-8.
7. Soslow RA, Wallace M, Goris J, Pedemonte-Coira BM, Smoller BR. MIC2 gene expression in cutaneous neuroendocrine carcinoma (Merkel cell carcinoma). Appl Immunohistochem 1996;4: 235-40.
8. Banerjee SS, Agbamu DA, Peyden B, Harris M. Clinicopathological characteristics of peripheral primitive neuroectodermal tumour of skin and subcutaneous tissue. Histopathology 1997;31:355-66.
9. Swanson PE, Jaszcz W, Nakhleh RE, Kelly DR, Dehner LP. Peripheral primitive neuroectodermal tumors. A flow cytometric analysis with immunohistochemical and ultrastructural observations. Arch Pathol Lab Med 1992;116:1202-8.
10. Smolle-Juettner FM, Smolle J, Richtig E, Kraus I, Popper H, Becker H. Primitive neuroectodermal tumor arising in the skin. Dermatology 1992;185:272-5.
11. Peters MS, Reiman HM, Muller SA. Cutaneous extraskeletal Ewing's sarcoma. J Cutan Pathol 1985;12:476-85.
12. Wick MR, Goellner JR, Scheithauer BW, Thomas JR, Sanchez NP, Schroeter AL. Primary neuroendocrine carcinomas of the skin (Merkel cell tumors). A clinical, histologic and ultrastructural study of thirteen cases. Am J Clin Pathol 1983;79:6-13.
13. Kao GF, Laskin WB, Weiss SW. Eccrine spiradenoma occurring in infancy mimicking a mesenchymal tumor. J Cutan Pathol 1990; 17:214-9.
14. Moll R, Lee I, Gould VE, Berndt R, Roessner A, Franke WW. Immunocytochemical analysis of Ewing's tumors. Patterns of expression of intermediate filaments and desmosomal proteins indicate cell type heterogeneity and pluripotential differentiation. Am J Pathol 1987;127:288-304.
15. Navairo S, Cavazzana AO, Llombart-Bosch A, Triche TJ. Comparison of Ewing's sarcoma of bone and peripheral neuroepithelioma. An immunocytochemical and ultrastructural analysis of two primitive neuroectodermal neoplasms. Arch Pathol Lab Med 1994; 118:608-15.
16. Wick MR, Swanson PE, Ritter JH, Fitzgibbon JF. Immunohistology of cutaneous neoplasia: a practical perspective. J Cutan Pathol 1993;20:481-97.
17. Swanson PE, Wick MR. Immunohistochemistry of diseases of the skin. In: Leong ASY, ed. Applied immunohistochemistry for the surgical pathologist. New York: Edward Arnold, 1994:269-308.
18. Ambros IM, Ambros PF, Strehl S, Kovar H, Gadner H, Salzer-Kuntschik M. MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Cancer 1991;67: 1886-93.
19. Fellinger EJ, Garin-Chesa P, Triche TJ, Huvos AG, Rettig WJ. Immunohistochemical analysis of Ewing's sarcoma cell surface antigen p30/32 MIC2. Am J Pathol 1991;139:317-25.
20. Stevenson AJ, Chatten J, Bertoni F, Miettinen M. CD99 (p30/32 MIC2) neurectodermal/Ewing's sarcoma antigen as an immunohistochemical marker. Review of more than 600 tumors and the literature experience. Appl Imunohistochem 1994;2:231-40.
21. Gelin C, Aubrit P, Phalipon A. The E2 antigen, a 32kd glycoprotein involved in T-cell adhesion processes, is the MIC2 gene product EMBO J 1989;8:3253-9.
22. Riopel M, Dickman PS, Link MP, Perlman EJ. MIC2 analysis in pediatric lymphomas and leukemias. Hum Pathol 1994;25:396-9.
23. Nicholson AG, Goldstraw P, Fisher C. Synovial sarcoma of the pleura and its differentiation from other primary pleural tumors: a clinicopathological and immunohistochemical review of three cases. Histopathology 1998;33:508-13.
24. Loo KT, Leung AKF, Chan JKC. Immunohistochemical staining of ovarian granulosa cell tumours with MIC2 antibody. Histopathology 1995;27:388-90.
25. Weidner N, Tjoe J. Immunohistochemical profile of monoclonal antibody O13: antibody that recognizes glycoprotein p30/32 MIC2 and is useful in diagnosing Ewing's sarcoma and peripheral neuroepithelioma. Am J Surg Pathol 1994;18:486-94.
26. Periman EJ, Dickman PS, Askin FB, Grier HE, Miser JS, Link MP. Ewing's sarcoma - routine diagnostic utilization of MIC2 analysis: a pediatric oncology group/children's cancer group intergroup study. Hum Pathol 1994;25:304-7.
27. Lumadue JA, Askin FA, Perlman EJ. MIC2 analysis of small cell carcinoma. Am J Clin Pathol 1994;102:692-4.
28. Moll R, Lowe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 1992;140:427-47.
29. Scott MP, Helm KF. Cytokeratin 20; a marker for diagnosing Merkel cell carcinoma. Am J Dermatopathol 1999;21:16-20.
30. Miettinen M. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Mod Pathol 1995;8:384-8.
31. Chan JKC, Suster S, Wenig BM, Tsang WY, Chan JB, Lau AL Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Am J Surg Pathol 1997;21:226-34.
32. Wick MR, Swanson PE Cutaneous adnexal tumors: a guide to pathologic diagnosis. Chicago: ASCP Press, 1991:1-77,169-87.
33. Hsu SM, Raine L, Fanger H. Use of the avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-81.
34. Sibley RK, Dehner LP, Rosai J. Primary neuroendocrine (Merkel cell?) carcinoma. I. A clinicopathologic and ultrastructural study of 43 cases. Am J Surg Pathol 1985;9:95-108.
35. Vortmeyer AO, Merino MJ, Bono R, LJotta LA, Cavazzana A, Zhuang Z. Genetic changes associated with primary merkel cell carcinoma. Am J Clin Pathol 1998;109:565-70.
36. Van Gele M, Speleman F, Vandesompele J, Van Roy N, Leonard JH: Characteristic pattern of chromosomal gains and losses in Merkel cell carcinoma detected by comparative genomic hybridization. Cancer Res 1998;58:1503-8.
37. Leonard JH, Hayard N. Loss of heterozygosity of chromosome 13 in Merkel cell carcinoma. Gene Chromosome Cancer 1997;20: 93-7.
38. Ballestin C, Nevado M, Gil-Martin R, Sanz-Anquela M, Lopez JI. Expression of keratin 20 in malignant eccrine poromas. Pathol Res Pract 1994;190:11-4.